- Home
- CELZ vs CNSP Comparison
CELZ vs CNSP Comparison
Compare CELZ & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELZ
- CNSP
- Stock Information
- Founded
- CELZ 1998
- CNSP 2017
- Country
- CELZ United States
- CNSP United States
- Employees
- CELZ N/A
- CNSP N/A
- Industry
- CELZ Biotechnology: Pharmaceutical Preparations
- CNSP Biotechnology: Pharmaceutical Preparations
- Sector
- CELZ Health Care
- CNSP Health Care
- Exchange
- CELZ Nasdaq
- CNSP Nasdaq
- Market Cap
- CELZ 4.7M
- CNSP 5.4M
- IPO Year
- CELZ N/A
- CNSP 2019
- Fundamental
- Price
- CELZ $2.07
- CNSP $0.11
- Analyst Decision
- CELZ
- CNSP Strong Buy
- Analyst Count
- CELZ 0
- CNSP 1
- Target Price
- CELZ N/A
- CNSP $0.50
- AVG Volume (30 Days)
- CELZ 23.2K
- CNSP 4.4M
- Earning Date
- CELZ 11-08-2024
- CNSP 11-15-2024
- Dividend Yield
- CELZ N/A
- CNSP N/A
- EPS Growth
- CELZ N/A
- CNSP N/A
- EPS
- CELZ N/A
- CNSP N/A
- Revenue
- CELZ $11,000.00
- CNSP N/A
- Revenue This Year
- CELZ N/A
- CNSP N/A
- Revenue Next Year
- CELZ N/A
- CNSP N/A
- P/E Ratio
- CELZ N/A
- CNSP N/A
- Revenue Growth
- CELZ N/A
- CNSP N/A
- 52 Week Low
- CELZ $1.96
- CNSP $0.10
- 52 Week High
- CELZ $10.28
- CNSP $70.00
- Technical
- Relative Strength Index (RSI)
- CELZ 32.53
- CNSP 45.26
- Support Level
- CELZ $1.96
- CNSP $0.10
- Resistance Level
- CELZ $2.50
- CNSP $0.12
- Average True Range (ATR)
- CELZ 0.21
- CNSP 0.01
- MACD
- CELZ -0.00
- CNSP 0.00
- Stochastic Oscillator
- CELZ 17.23
- CNSP 41.38
About CELZ Creative Medical Technology Holdings Inc.
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.
About CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.